Health Headlines 9/8/06

Estrens Might Not Be The Answer For Osteoporosis ~> Click here.

Virus Pulls The Trigger For Autoimmunity ~> Click here.

Maxygen Initiates Phase I Clinical Trial For Maxy-G34 For Chemotherapy-induced Neutropenia ~> Click here.

Hope Offered To Patients With Lung And Joint Disease By Key Study ~> Click here.

How Central Nervous System Regulates Arthritis ~> Click here.

New Approach To Rheumatoid Arthritis ~> Click here.

Licensing Arrangement Reached For Antiepileptic Drug Developed At Hebrew University ~> Click here.

Peninsula Medical School Research Team's Breakthrough In Fight To Combat Diabetes ~> Click here.

Rigel Announces Initiation Of Phase II Study Evaluating R788 In Rheumatoid Arthritis ~> Click here.

Genzyme Begins Phase 3 Pivotal Study Of Clolar(R) In Adult Acute Myelogenous Leukemia ~> Click here.

Breast Density Important Predictor For Breast Cancer Risk ~> Click here.

US Cancer Death Totals Drop, Rate Of New Cancers Stable ~> Click here.

Diabetic Leg Ulcers Reduced By Pine Tree Bark ~> Click here.

Abbott Submits U.S. And E.U. Regulatory Applications Seeking Approval For HUMIRA(R) (Adalimumab) As A Treatment For Crohn's Disease ~> Click here.

Jazz Pharmaceuticals Announces Phase III Clinical Trial To Study The Safety And Efficacy Of Xyrem(R) In Patients With Fibromyalgia Syndrome ~> Click here.

SYMLIN Improved Diabetes Control In Patients With Type 2 Diabetes On Established Regimens Of Basal Insulin ~> Click here.

FDA Releases Draft Guidelines Regulating Complex Diagnostic Tests, Including Those For Breast, Ovarian Cancers ~> Click here.